Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Toshimichi Ishihara"'
Autor:
Hajime Senjo, Masahiro Onozawa, Daisuke Hidaka, Shota Yokoyama, Satoshi Yamamoto, Yutaka Tsutsumi, Yoshihito Haseyama, Takahiro Nagashima, Akio Mori, Shuichi Ota, Hajime Sakai, Toshimichi Ishihara, Takuto Miyagishima, Yasutaka Kakinoki, Mitsutoshi Kurosawa, Hajime Kobayashi, Hiroshi Iwasaki, Daigo Hashimoto, Takeshi Kondo, Takanori Teshima
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Acute myeloid leukemia (AML) patients older than 65 years have a poor prognosis. Recently, CAR (C-reactive-protein/albumin ratio) has been actively reported as a prognostic index reflecting the nutritional and inflammatory status of elderly
Externí odkaz:
https://doaj.org/article/d095279bc4394d4594cd9a7be8a12ae9
Autor:
Tomoyuki Saga, Michiyo Kanagawa, Tomoya Harada, Lang Lang, Fumihiko Yamawaki, Toshimichi Ishihara
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 6, p781-790, 10p
Autor:
Shota Yokoyama, Masahiro Onozawa, Shota Yoshida, Naoki Miyashita, Hiroyuki Kimura, Shogo Takahashi, Toshihiro Matsukawa, Hideki Goto, Shinichi Fujisawa, Kosuke Miki, Daisuke Hidaka, Junichi Hashiguchi, Kentaro Wakasa, Makoto Ibata, Yukari Takeda, Akio Shigematsu, Katsuya Fujimoto, Yutaka Tsutsumi, Akio Mori, Toshimichi Ishihara, Yasutaka Kakinoki, Takeshi Kondo, Daigo Hashimoto, Takanori Teshima
Publikováno v:
British Journal of Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4a7c1e597e851d9236a5a325c2520ee
https://doi.org/10.1111/bjh.18800
https://doi.org/10.1111/bjh.18800
Autor:
Naoki Miyashita, Masahiro Onozawa, Shota Yoshida, Hiroyuki Kimura, Shogo Takahashi, Shota Yokoyama, Toshihiro Matsukawa, Shinsuke Hirabayashi, Shinichi Fujisawa, Akio Mori, Shuichi Ota, Yasutaka Kakinoki, Yutaka Tsutsumi, Satoshi Yamamoto, Takuto Miyagishima, Takahiro Nagashima, Makoto Ibata, Kentaro Wakasa, Yoshihito Haseyama, Katsuya Fujimoto, Toshimichi Ishihara, Hajime Sakai, Takeshi Kondo, Takanori Teshima
Publikováno v:
International Journal of Hematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::016474bbb0cb329f0189405bd8ce0495
https://doi.org/10.1007/s12185-023-03567-1
https://doi.org/10.1007/s12185-023-03567-1
Autor:
Shota Yoshida, Masahiro Onozawa, Naoki Miyashita, Hiroyuki Kimura, Shogo Takahashi, Shota Yokoyama, Toshihiro Matsukawa, Shinsuke Hirabayashi, Akio Mori, Daisuke Hidaka, Koichiro Minauchi, Akio Shigematsu, Junichi Hashiguchi, Tetsuyuki Igarashi, Yasutaka Kakinoki, Yutaka Tsutsumi, Makoto Ibata, Hajime Kobayashi, Yoshihito Haseyama, Katsuya Fujimoto, Toshimichi Ishihara, Hajime Sakai, Shuichi Ota, Takeshi Kondo, Takanori Teshima
Publikováno v:
Blood. 140:3210-3211
Complex karyotype acute myeloid leukemia (CK-AML) has been classified as an adverse-risk subtype. Although a few reports have further classified CK-AML as typical (including monosomy of chromosomes 5, 7 and 17 or deletion of 5q, 7q and/or 17p) or aty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a78bb2d77bdd433bdb0310bf13987dca
https://doi.org/10.1182/blood-2022-157874
https://doi.org/10.1182/blood-2022-157874
Autor:
Shota Yokoyama, Masahiro Onozawa, Shota Yoshida, Naoki Miyashita, Hiroyuki Kimura, Shogo Takahashi, Toshihiro Matsukawa, Shinichi Fujisawa, Kosuke Miki, Daisuke Hidaka, Junichi Hashiguchi, Kentaro Wakasa, Makoto Ibata, Yukari Takeda, Akio Shigematsu, Katsuya Fujimoto, Yutaka Tsutsumi, Akio Mori, Toshimichi Ishihara, Yasutaka Kakinoki, Takeshi Kondo, Takanori Teshima
Publikováno v:
Blood. 140:9094-9095
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::693a4d25a4b230f18dd80a079dd8b92b
https://doi.org/10.1182/blood-2022-162325
https://doi.org/10.1182/blood-2022-162325
Autor:
Naoki Miyashita, Masahiro Onozawa, Shota Yoshida, Hiroyuki Kimura, Shogo Takahashi, Shota Yokoyama, Toshihiro Matsukawa, Shinsuke Hirabayashi, Shinichi Fujisawa, Akio Mori, Shuichi Ota, Yasutaka Kakinoki, Yutaka Tsutsumi, Satoshi Yamamoto, Takuto Miyagishima, Takahiro Nagashima, Makoto Ibata, Hajime Kobayashi, Yoshihito Haseyama, Katsuya Fujimoto, Toshimichi Ishihara, Hajime Sakai, Takeshi Kondo, Takanori Teshima
Publikováno v:
Blood. 140:8950-8951
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e74e6ba6db4da875a65ce883c1bddc1
https://doi.org/10.1182/blood-2022-158653
https://doi.org/10.1182/blood-2022-158653
Autor:
Hiroyuki Kimura, Masahiro Onozawa, Shota Yoshida, Naoki Miyashita, Shogo Takahashi, Shota Yokoyama, Toshihiro Matsukawa, Shinsuke Hirabayashi, Shinichi Fujisawa, Shuichi Ota, Daisuke Hidaka, Akio Mori, Takeshi Kondo, Yasutaka Kakinoki, Yutaka Tsutsumi, Satoshi Yamamoto, Takuto Miyagishima, Takahiro Nagashima, Makoto Ibata, Hajime Kobayashi, Yoshihito Haseyama, Katsuya Fujimoto, Toshimichi Ishihara, Hajime Sakai, Takanori Teshima
Publikováno v:
Blood. 140:9207-9208
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d56bb461097749e9189511a4f37da442
https://doi.org/10.1182/blood-2022-157881
https://doi.org/10.1182/blood-2022-157881
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 61(3)
Richter syndrome (RS) is the development of an aggressive lymphoma in patients with chronic lymphocytic leukemia (CLL). Most cases of diffuse large B-cell lymphoma variant of RS are clonally related to the original CLL. Here, we present a case of man
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::460c6fc5440499d3f8f3d6ca324735ea
https://pubmed.ncbi.nlm.nih.gov/32224586
https://pubmed.ncbi.nlm.nih.gov/32224586
Autor:
Hajime Senjo, Yoshihito Haseyama, Shota Yokoyama, Takahiro Nagashima, Hajime Kobayashi, Masahiro Onozawa, Takanori Teshima, Hajime Sakai, Takeshi Kondo, Daisuke Hidaka, Takuto Miyagishima, Mitsutoshi Kurosawa, Satoshi Yamamoto, Daigo Hashimoto, Hiroshi Iwasaki, Akio Mori, Toshimichi Ishihara, Shuichi Ota, Yutaka Tsutsumi, Yasutaka Kakinoki
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-7 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-7 (2020)
Elderly patients aged 65 or older with acute myeloid leukemia (AML) have poor prognosis. The risk stratification based on genetic alteration has been proposed in national comprehensive cancer network (NCCN) guideline but its efficacy was not well ver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::229dbff8062e78f240a28af0b9def5f8
https://pubmed.ncbi.nlm.nih.gov/33173122
https://pubmed.ncbi.nlm.nih.gov/33173122